I am liking the continual drops in ABT. I will continue adding as long as it keeps dropping below my last purchase price and I am still underweight.
I will also be adding to AMGN. Both ABT and AMGN are already set to be bought tomorrow morning and will help add more to my healthcare allocation.
ABT - $500
AMGN - $500
I also have cash on the side debating whether I should also buy other healthcare companies that I have been watching for a long time. These names include stuff like BDX, JNJ, MDT, and GILD all of which have fallen quite decently in the last several weeks. Stay tuned.
I added a new position with ABT today. I agree it is a good time to load up on healthcare. Congratulations on your ABT and AMGN purchases. They have a good history of growth.
ReplyDeleteD4s
Jnj, pg, are pretty good buys right now. As some of my positions are falling under 10%, I'd prefer to add those stocks to average down rather than adding new position. However, either way would work. You see most stocks are down 20-70% from the 52-week high, it had already been corrected. We will not see the down coming down to 7000 like 2009. I guess, never say never, but the situation has changed since then. Plus, I'd rather see my money working for me right now earning dividends, than sitting at the bank earning close to 0% interest rate.
ReplyDeleteThe "correction" so far was very much needed. We needed some breathing room after the nonstop increase in share prices. Since I am in the accumulation phase, I am hoping the market will continue with the negative sentiment. If you read the news, you hear fear and doom&gloom. JNJ is my favorite healthcare company that I would add now if I didn't have a full position. It is in line with historical valuation and has stable earnings. I'm more worried about PG's ability to increase earnings but I do believe they will turn around eventually.
DeleteNice purchases. I just picked up some AMGN last week, which it turns out was too soon. Im still happy to hold a good sized position in the company though. Looking forward to the div raise next month
ReplyDeleteR2R
Biotechnology stocks have seen a lot of growth but I think their favor may have gone out. Who knows we shall see what will happen in the coming months. I will just dollar cost average little bits at a time. Biotech stocks are volatile and most of them do not pay a dividend, I prefer to keep Biotechs a lower % of my healthcare allocation. I like to stick with higher quality names like GILD and AMGN that do pay a dividend, but CELG and BIIB may be speculative plays I can consider if they fall severely.
Delete